Fraser Black – CEO
Fraser spent 2 years at NERC Institute of Virology Oxford as a research scientist before moving to the first step in his commercial roles with Amersham International. He has over 30 years’ commercial experience (sales, marketing, and business and market development) in the Bioscience industry. He lived and worked in UK, Germany and the US in a variety of sectors that included President of Hoefer Pharmacia, San Francisco, Vice-President of Service, Americas for Amersham Biosciences and Global GM for Scientific Asset Services for GE Healthcare, Life Science Division. Fraser has taken leadership roles as Managing Director of BioCity Scotland and latterly as Managing Director of James Hutton Limited where the emphasis has been very much on the interface of academia, industry and government to drive industry lead Commercialisation of IP by building a Professional Services delivery approach. He has a passion for both the development and adoption of innovation to drive health and wealth. Fraser was recently on the Board of Opportunity North East which secured £30M for a Life Science Innovation Hub in Aberdeen and is a member of The Life Sciences Industry Leadership Group, that advises the Scottish Government.